Pharma giant Novo Nordisk, the company behind Wegovy and Ozempic, expects to launch six products in the next five years. Leading the pack of new drugs will be CagriSema.

The AP-NORC survey shows about half of U.S. adults believe it is a good thing for adults to use Ozempic, Wegovy and similar ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Novo Nordisk’s NVO shares gained 8.5% on Friday after the company announced positive top-line data from an early to mid-stage ...

Lizzo shares inspiring weight loss journey update, achieving her 'weight release goal' and emphasizing sustainable health changes. Discover her insights on fitness and self-care.

The new drug, amycretin, similar to the company's blockbuster weight ... Ozempic, provided weight loss of up to 22% in ...

The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class of drugs called glucagon-like peptide-1 agonists, or GLP-1.

Walking is clearly having a comeback-meets-glow-up of sorts, but it’s easy to miss a crucial detail when wading through workout plans and gear recs: How long should I walk to lose weight on a ...

You may take Ozempic or another drug to control your diabetes or lose weight, but these so-called GLP-1s also have a host of other effects ‒ some good and some not so good. A new study ...

Research into whether it could be a safe or effective aid for people who want to lose weight is ongoing ... to confirm the results, correct dosage, and safety of berberine. However, these effects ...